EMA
approval
· 2023-04-11
EMA Authorised: Granpidam (sildenafil citrate) — Accord Healthcare S.L.U.
Summary
Granpidam (sildenafil citrate) has been authorised in the EU for use in hypertension and pulmonary hypertension with Accord Healthcare S.L.U. as the marketing a…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Authorised. Therapeutic area: Hypertension, Pulmonary. MAH: Accord Healthcare S.L.U.. Decision date: 30/03/2023